VeriMomБезопасен ли sodium c12-15 pareth-7 sulfonate при беременности?
No harmonised CLP reproductive classification (ECHA Annex VI) or SCCS/CIR reproductive warning found for sodium C12–15 pareth-7 sulfonate. Regulatory and safety-assessment sources treat ethoxylated alkyl sulfonate surfactants as low systemic-reprotoxicity in cosmetic use (CIR / SCCS style conclusions) and there are no peer-reviewed reports of teratogenicity or human reproductive effects for this specific ingredient. Dermal cosmetic use can give low but measurable exposure; therefore exposure score is 1. Sources: ECHA Annex VI (no harmonised classification), CIR/SCCS style safety literature, PubChem/CosIng entries (no reproductive flags).
Related ingredients
Frequently asked questions
- Безопасен ли sodium c12-15 pareth-7 sulfonate при беременности?
- No harmonised CLP reproductive classification (ECHA Annex VI) or SCCS/CIR reproductive warning found for sodium C12–15 pareth-7 sulfonate. Regulatory and safety-assessment sources treat ethoxylated alkyl sulfonate surfactants as low systemic-reprotoxicity in cosmetic use (CIR / SCCS style conclusions) and there are no peer-reviewed reports of teratogenicity or human reproductive effects for this specific ingredient. Dermal cosmetic use can give low but measurable exposure; therefore exposure score is 1. Sources: ECHA Annex VI (no harmonised classification), CIR/SCCS style safety literature, PubChem/CosIng entries (no reproductive flags).
- Безопасен ли sodium c12-15 pareth-7 sulfonate при грудном вскармливании?
- No evidence of reproductive or lactation-related toxicity or known mechanisms for transfer into breast milk for this ingredient; no harmonised hazard classification. Dermal cosmetic use implies low but measurable maternal systemic exposure, so a low exposure score is used. Sources: ECHA records (no harmonised classification), CosIng/PubChem (no lactation concerns), absence of CIR/SCCS warnings.
- Безопасен ли sodium c12-15 pareth-7 sulfonate для кожи малыша?
- No infant-specific reproductive or developmental hazards identified for this surfactant. However, immature infant skin has higher permeability and higher surface-area-to-weight, so exposure score is increased by +1 from adult (adult e=1 → infant e=2). No infant-specific adverse data found in regulatory or peer-reviewed sources. Sources: CosIng/PubChem (ingredient identity and typical use), ECHA (no harmonised classification), toxicology literature absence per CIR/SCCS practice.
- Как VeriMom оценивает sodium c12-15 pareth-7 sulfonate?
- VeriMom оценивает sodium c12-15 pareth-7 sulfonate в 93/100 (без известных рисков) на основе EU CosIng, классификаций ECHA и исследований PubMed.
- Какие безопасные альтернативы sodium c12-15 pareth-7 sulfonate при беременности?
- См. наш список безопасных альтернатив sodium c12-15 pareth-7 sulfonate с аналогичной функцией и классификацией без известных рисков.
Проверь любой состав за 2 секунды
Скачай VeriMom бесплатно — отсканируй любой продукт и мгновенно получи оценку безопасности при беременности.
Медицинская оговорка
Данная информация предоставлена исключительно в образовательных целях и не является медицинской рекомендацией. Оценки безопасности основаны на общедоступных данных и могут не отражать все риски. Всегда консультируйтесь с вашим врачом перед использованием любых средств во время беременности или грудного вскармливания.